Erectile dysfunction
Conditions
Interventions
Test group:"Da Jing" (3 capsules/day) combined with PDE5I (tadalafil) treatment
Control groups:"Placebo" (3 capsules/day) + PDE5I (tadalafil) monotherapy.
Sponsors
Northern Jiangsu People's Hospital Affiliated to Yangzhou University
Eligibility
Sex/Gender
Male
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) 20 years = age = 60 years; (2) IIEF-5 = 11; (3) Meets the western medical diagnosis (persistent inability of the penis to achieve or maintain an erection sufficient to accomplish a satisfactory sexual life); (4) Having a stable partner and regular sexual life; (5) Not taking drugs that affect this clinical study within 1 month; (6) Those who voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) ED due to spinal cord injury, history of radical prostatectomy, or trauma; (2) Those with penile deformity or genital dysplasia; (3) Those with a combination of severe cardiovascular or cerebrovascular diseases or other organ diseases; (4) People with mental disorder diseases; (5) People with contraindications or allergies to the study drug; (6) Those who have inflammation or stones in the genitourinary system; (7) Those who are receiving tumor chemotherapy, anti-androgen therapy; (8) Participating in other drug experiments at the same time or poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brief International Erectile Function Questionnaire (IIEF-5);Erectile Hardness Scale (EHS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety Symptoms Screening Scale (GAD-7);PHQ-9 Depression Screening Scale; | — |
Countries
China
Contacts
Public ContactKaifeng Liu
Northern Jiangsu People's Hospital Affiliated to Yangzhou University
Outcome results
None listed